Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-007407-86Phase 3Completed
Phase 3, randomised, double-blind trial in chronic heart failure (CHF) comparing Levosimendan pulsed infusion with Placebo pulsed infusion (2 arms). Primary endpoint: Composite functional capacity and quality of life response at 28 weeks. Started Jul 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-007407-86.